001540 — AHN-GOOK PHARMACEUTICAL Co Share Price
Last trade - 00:00- KR₩81bn
- KR₩130bn
- KR₩234bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.49 | ||
| Price to Tang. Book | 0.5 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | 12.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.37% | ||
| Return on Equity | 9.54% | ||
| Operating Margin | 2.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 155,851.76 | 143,364.22 | 163,533.83 | 205,388.54 | 233,675.5 | n/a | n/a | 4.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -69.72 | n/a | n/a | +93.83 | -81.94 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.
Directors
- Jun Seon Uh CHM (76)
- Jin Uh CCE (49)
- Se Yeong Cheon OTH (49)
- Ha Taek Jung OTH (77)
- Cheol Min Kim OTH (48)
- Jeong Hun Kim OTH (50)
- Jae Jun Jung NID (54)
- Chun Sang Park NID (47)
- Heung Jun Yang NID (67)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 12th, 1959
- Public Since
- June 15th, 2000
- No. of Shareholders
- 12,491
- No. of Employees
- 606
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 11,365,365
- Address
- A Dong, SEOUL, 13840
- Web
- http://www.ahn-gook.com/
- Phone
- +82 232894226
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 001540
Similar to 001540
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
Anterogen Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:07 UTC, shares in AHN-GOOK PHARMACEUTICAL Co are trading at KR₩7,160. This share price information is delayed by 15 minutes.
Shares in AHN-GOOK PHARMACEUTICAL Co last closed at KR₩7,160 and the price had moved by -4.04% over the past 365 days. In terms of relative price strength the AHN-GOOK PHARMACEUTICAL Co share price has underperformed the FTSE Developed Asia Pacific Index by -19.82% over the past year.
There is no consensus recommendation for this security.
Find out moreThe AHN-GOOK PHARMACEUTICAL Co dividend yield is 3.07% based on the trailing twelve month period.
Last year, AHN-GOOK PHARMACEUTICAL Co paid a total dividend of KR₩220, and it currently has a trailing dividend yield of 3.07%. We do not have any data on when AHN-GOOK PHARMACEUTICAL Co is to next pay dividends.
We do not have data on when AHN-GOOK PHARMACEUTICAL Co is to next pay dividends. The historic dividend yield on AHN-GOOK PHARMACEUTICAL Co shares is currently 3.07%.
To buy shares in AHN-GOOK PHARMACEUTICAL Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩7,160, shares in AHN-GOOK PHARMACEUTICAL Co had a market capitalisation of KR₩81bn.
Here are the trading details for AHN-GOOK PHARMACEUTICAL Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 001540
Based on an overall assessment of its quality, value and momentum AHN-GOOK PHARMACEUTICAL Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AHN-GOOK PHARMACEUTICAL Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -15.26%.
As of the last closing price of KR₩7,160, shares in AHN-GOOK PHARMACEUTICAL Co were trading -10.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AHN-GOOK PHARMACEUTICAL Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩7,160.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AHN-GOOK PHARMACEUTICAL Co's management team is headed by:
- Jun Seon Uh - CHM
- Jin Uh - CCE
- Se Yeong Cheon - OTH
- Ha Taek Jung - OTH
- Cheol Min Kim - OTH
- Jeong Hun Kim - OTH
- Jae Jun Jung - NID
- Chun Sang Park - NID
- Heung Jun Yang - NID